Last updated: June 23, 2023
Sponsor: University of Monastir
Overall Status: Active - Recruiting
Phase
N/A
Condition
Covid-19
Treatment
Spray with Hypochlorous Acid Group
Spray with Placebo Group
Clinical Study ID
NCT05862480
Monastir URG
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
- Inclusion Criteria :
- Patients with symptoms of COVID who are over 18 years of age and whose nasalswabs have been positive for SARS-CoV-2 based on RT-PCR testing less than 3 days .
- Patients must have the ability to understand and be willing to sign a writteninformed consent document from the patient or legal representative.
- The patient must be able and willing to comply with the requirements of thisstudy protocol.
Exclusion
- Exclusion Criteria:
- History of allergy to hypochlorous acid solution .
- Oral lesions contraindicating the use of hypochlorous acid solution.
- Patients receiving any other investigational agent in a clinical trial.
- Intubated patient on mechanical ventilation or with uncontrolled disease :congestive heart failure, IDM, uncontrolled epilepsy or psychiatric illness.
- Uncertain patient follow-up during the study.
Study Design
Total Participants: 400
Treatment Group(s): 2
Primary Treatment: Spray with Hypochlorous Acid Group
Phase:
Study Start date:
May 15, 2023
Estimated Completion Date:
September 30, 2023
Study Description
Connect with a study center
Semir Nouira
Monastir, 5000
TunisiaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.